Coherus BioSciences (NASDAQ:CHRS) reported its Q1 earnings results on Thursday, May 5, 2022 at 05:01 PM.
Here's what investors need to know about the announcement.
Earnings
Coherus BioSciences missed estimated earnings by 108.33%, reporting an EPS of $-1.0 versus an estimate of $-0.48.
Revenue was down $22.92 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 4.12% drop in the share price the next day.
Here's a look at Coherus BioSciences's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.51 | -0.22 | -0.17 | 0.06 |
| EPS Actual | -0.46 | -0.34 | -0.36 | 0.01 |
| Revenue Estimate | 85.81M | 91.31M | 89.81M | 96.00M |
| Revenue Actual | 73.37M | 82.50M | 87.64M | 83.03M |
To track all earnings releases for Coherus BioSciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
